Schedule 13G ownership disclosure

MERSANA THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 59045L106

Event date: 2024-12-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nextech Crossover I GP S.a. r.l.

    Shares: 12,067,246.00 · Class: 10.4%

  • Nextech Crossover I SCSp

    Shares: 12,067,246.00 · Class: 10.4%

  • Ian Charoub

    Shares: 12,067,246.00 · Class: 10.4%

  • Costas Constantinides

    Shares: 12,067,246.00 · Class: 10.4%

  • Rocco Sgobbo

    Shares: 12,067,246.00 · Class: 10.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-24-030159
Form type
SCHEDULE 13G/A
Filer
Mersana Therapeutics, Inc.
CIK
CIK 1442836
Filed
Dec 26, 2024
Reporting period
Dec 20, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub